Article
Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease.
Current drug targets - 1 Jan 2017
Liu Xiangwei, Sun Aijun
Abstract excerpt
BACKGROUND: Coronary heart disease is the leading cause of mortality and morbidity, incurring a major burden of medical care. Even with increasing application of emergent recanalization (PCI and CABG) therapy, ischemia and ischemic reperfusion injury remain as the dominant pathological process that damages cardiomyocytes. Mitochondrial Aldehyde dehydrogenase-2 (ALDH2) is a multifunctional enzyme catalyzing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
